The failure of inhibition of MAPK and/or PI3K signaling to recapitulate the effects of suppressing NRAS oncogene expression in the tNM AML model led us to hypothesize that RALB, a less well characterized Ras effector pathway, might provide critical survival signals downstream of Ras in AML. This evidence concerns the gene RALB and acute myeloid leukemia.